Earnings Feed
Start Free
CATALYST PHARMACEUTICALS, INC.·4

Dec 17, 5:24 PM ET

Miller Steve 4

4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 17, 2024

Insider Transaction Report

Form 4
Period: 2024-12-13
CATALYST PHARMACEUTICALS, INC.CPRX
Miller Steve
VP Development & Management
Transactions
  • Exercise/Conversion

    Options to purchase common stock

    2024-12-13−235,000→ 1,552,176 total
    Exercise: $4.01Exp: 2025-01-02→ Common Stock (235,000 underlying)
  • Exercise/Conversion

    Common stock, par value $0.001 per share

    2024-12-13$4.01/sh+235,000$942,350→ 921,996 total
Footnotes (1)
  • [F1]Options vested in three annual tranches beginning on January 2, 2019.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4 FOR 12-13-2024